Yanai Shlomo is a director of Amneal Pharmaceuticals Inc.
Person profile
Roles
Amneal Pharmaceuticals
Director
Philip Morris International
Director
Address
East Rutherford, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Amneal Pharmaceuticals, Inc.
10 May 22
4
Philip Morris International Inc.
6 May 22
4
W R GRACE & CO
22 Sep 21
4
W R GRACE & CO
12 May 21
4
Philip Morris International Inc.
7 May 21
3
Philip Morris International Inc.
7 May 21
4
Amneal Pharmaceuticals, Inc.
7 May 21
4
Amneal Pharmaceuticals, Inc.
18 Dec 20
4
W R GRACE & CO
14 May 20
4
Amneal Pharmaceuticals, Inc.
6 May 20
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 May 22 | AMRX Amneal Pharmaceuticals | RSU Class A Common Stock | Grant | Acquire A | No | No | 0 | 80,128 | 0.00 | 80,128 |
| 8 May 22 | AMRX Amneal Pharmaceuticals | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 35,406 | 0.00 | 89,146 |
| 8 May 22 | AMRX Amneal Pharmaceuticals | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 35,406 | 0.00 | 0 |
| 4 May 22 | PM Philip Morris International | Common Stock | Grant | Acquire A | No | No | 99.53 | 1,759 | 175.07 k | 3,598 |